Duodenal Stent Sales

Duodenal Stent Sales Market Outlook

The global duodenal stent market is projected to reach USD 1.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025-2035. Factors fueling the growth of this market include the increasing prevalence of gastrointestinal disorders, advancements in stent technology improving patient outcomes, and rising demand for minimally invasive procedures that offer quicker recovery times. Additionally, an aging population prone to various digestive diseases is expected to drive the market further. The expanding healthcare infrastructure in emerging markets and the growing awareness of treatment options will also contribute to the market's growth trajectory. The increasing investment in research and development is likely to lead to innovative product offerings, thereby enhancing market expansion.

Growth Factor of the Market

The duodenal stent market is significantly influenced by several growth factors that enhance its potential. Firstly, the rising incidence of gastrointestinal conditions such as duodenal obstructions and cancers requires efficient management solutions, thus driving the demand for stenting devices. Additionally, the shift towards minimally invasive surgical procedures has made stenting a preferred option among healthcare providers, encouraging further adoption. Technological advancements in stent design and materials are also critical, as they improve the efficacy and safety of stents, thereby boosting their acceptance among clinicians. Furthermore, increased government funding and healthcare spending in various regions, particularly in emerging economies, are facilitating better access to advanced medical devices. Finally, the growing trend of outpatient treatments and the establishment of more ambulatory surgical centers are promoting the use of duodenal stents in diverse patient settings.

Key Highlights of the Market

• The duodenal stent market is expected to grow at a CAGR of 6.8% from 2025 to 2035.
• Self-expandable metal stents are anticipated to dominate the market share due to their effectiveness and reliability.
• North America holds the largest market share, driven by advanced healthcare infrastructure and higher disease prevalence.
• The increasing adoption of minimally invasive surgical techniques is a major driver for market expansion.
• Research and development activities are paving the way for innovative stent designs and materials.

By Product Type

Self-Expandable Metal Stents:

Self-expandable metal stents (SEMS) are projected to capture a substantial share of the duodenal stent market due to their high efficacy rate and adaptability in various clinical situations. These stents are designed to expand automatically upon deployment, providing reliable support to the duodenum and alleviating obstructions caused by tumors or other factors. Their ability to conform to the anatomy of the gastrointestinal tract enhances their functionality and reduces complications. Moreover, SEMS have been shown to improve patient quality of life significantly, as they minimize the need for repeated interventions. The successful clinical outcomes associated with these stents, coupled with ongoing advancements in their design and manufacturing, are anticipated to further bolster their market penetration in the coming years.

Plastic Stents:

Plastic stents are commonly utilized for temporary solutions in managing duodenal obstructions. They offer several advantages, including lower costs and ease of placement compared to metal stents. These stents are particularly effective in benign conditions and short-term applications. While their longevity is less compared to self-expandable metal stents, they are often utilized in cases where there is a possibility of stent migration or when patients require a more provisional solution. The growing awareness regarding their benefits, along with the rise in outpatient procedures, is likely to enhance the demand for plastic stents in the duodenal stent segment.

Covered Stents:

Covered stents have gained traction in the duodenal stent market due to their ability to prevent tissue ingrowth and reduce the risk of obstruction recurrence. These stents are lined with a biocompatible material that helps to minimize complications associated with stent placement. They are particularly preferred in malignant cases where the risk of tumor infiltration is high. The effectiveness of covered stents in prolonging patency and improving patient outcomes positions them as a favorable choice among surgeons. Continuous enhancements in the materials used for covered stents are expected to drive their adoption further, as clinicians seek more reliable solutions for managing complex gastrointestinal conditions.

Drug-Eluting Stents:

Drug-eluting stents represent an innovative advance in the duodenal stent market, combining drug delivery with stent functionality. These stents release therapeutic agents that inhibit cell proliferation and inflammation, thereby reducing the risk of restenosis. The application of drug-eluting technology in the gastrointestinal space is still emerging, but the positive clinical results associated with their use are driving interest from healthcare providers. As research continues to validate their effectiveness, drug-eluting stents are likely to see increased adoption, especially in patients with a high risk of complications from conventional stenting techniques. Their potential to enhance patient outcomes will play a vital role in shaping the future landscape of duodenal interventions.

Others:

The "Others" category encompasses various innovative stenting solutions developed for specific clinical needs. This segment may include bioabsorbable stents, which have the potential to dissolve over time and minimize long-term complications associated with permanent implants. Additionally, specialized stents designed for unique anatomical variations or conditions are considered in this category. The demand for customized and patient-specific solutions is likely to drive innovation in this area, leading to the introduction of new products that cater to niche markets within the overall duodenal stent landscape. As healthcare continues to evolve, this segment is expected to grow alongside advancements in medical technology.

By Application

Malignant Obstruction:

Malignant obstructions are a primary application for duodenal stents, as they are frequently encountered in patients with advanced cancers affecting the gastrointestinal tract. These stents play a crucial role in palliation, allowing for improved nutritional intake and quality of life in patients suffering from obstructive symptoms due to tumors. The choice of stent type often depends on the location and extent of the obstruction, as well as the patient's overall condition. As the prevalence of gastrointestinal cancers continues to rise globally, the demand for effective management strategies, including the use of duodenal stents for malignant obstructions, is expected to grow significantly in the foreseeable future. Additionally, ongoing research into the effectiveness of different stent types for this application will likely enhance treatment options for patients.

Benign Obstruction:

Benign obstructions, resulting from conditions such as strictures, inflammation, or post-surgical complications, represent another significant application of duodenal stenting. The use of stents in these cases aims to alleviate symptoms and restore normal gastrointestinal function. The demand for stenting solutions in benign cases is driven by the success of minimally invasive procedures that offer less risk and faster recovery times compared to traditional surgical interventions. The increasing preference for outpatient treatments complements the growing utilization of duodenal stents for benign obstructions, as healthcare providers and patients alike seek effective alternatives to manage gastrointestinal issues. Innovations in stent design and materials are continuously improving the outcomes for patients with benign obstructions.

Fistula:

Fistula management is an emerging application of duodenal stents, particularly in patients with complex gastrointestinal conditions. Stenting can be employed to address enteric fistulas, which may result from inflammatory bowel disease or post-surgical complications. The use of stents in fistula cases aims to facilitate healing by providing structural support and preventing the passage of luminal contents through the abnormal connection. With the growing recognition of minimally invasive approaches in managing fistulas, the application of duodenal stents is likely to gain traction. As more healthcare professionals become aware of the benefits of stenting in this context, the demand for such interventions is expected to increase substantially.

Pyloric Obstruction:

Pyloric obstruction, often encountered in conditions such as gastric cancer or severe peptic ulcer disease, can lead to significant patient morbidity due to vomiting and nutritional deficiencies. Duodenal stenting serves as an effective solution to relieve these symptoms by allowing gastric contents to pass into the duodenum and beyond. The rising incidence of pyloric obstructions, coupled with the benefits of minimally invasive stenting, is expected to drive demand in this application area. Factors such as the aging population and lifestyle-related diseases that contribute to gastrointestinal obstructions will further bolster the need for stenting interventions specifically for pyloric obstructions.

Others:

The "Others" application segment for duodenal stents includes various other conditions that may necessitate stenting. This could involve specific anatomical challenges or unique patient presentations that do not fall under the traditional categories of obstruction or fistula management. As the medical community continues to explore innovative solutions for gastrointestinal issues, the identification of new applications for duodenal stents may arise. Emerging research and clinical studies will likely uncover additional indications for stenting, leading to a broader acceptance of these devices across diverse gastrointestinal conditions. This segment shows promise for growth as healthcare providers adapt to the evolving landscape of gastrointestinal interventions.

By User

Hospitals:

Hospitals remain the primary end-user of duodenal stents, accounting for a significant portion of the market. These institutions are equipped with advanced surgical facilities and specialized personnel capable of performing complex procedures involving stent placements. The increasing number of surgical interventions and the demand for effective treatment modalities for gastrointestinal disorders are driving hospitals to adopt duodenal stents more widely. Additionally, hospitals often have access to the latest stenting technologies and are involved in clinical trials, further contributing to their dominant position in the market. As healthcare systems continue to evolve and expand, hospitals are expected to maintain a substantial share of the duodenal stent market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are experiencing significant growth as end-users of duodenal stents, driven by the trend towards outpatient procedures. These facilities focus on providing same-day surgical care, which enhances patient convenience and reduces healthcare costs. The utilization of duodenal stenting in ASCs allows for minimally invasive interventions that can be efficiently managed within the outpatient setting. The rising preference for outpatient surgeries, combined with the development of cutting-edge stenting technologies, is anticipated to bolster the role of ASCs in the duodenal stent market. As more patients seek alternatives to traditional hospital stays, ASCs are well-positioned to capitalize on this trend.

Specialty Clinics:

Specialty clinics, focusing on specific areas of gastrointestinal care, represent a growing segment in the duodenal stent market. These clinics often provide targeted interventions for patients with unique gastrointestinal disorders, and their specialized training allows for advanced stenting techniques. As the demand for specialized care increases, specialty clinics are increasingly adopting duodenal stents as part of their treatment plans. The ability to offer personalized care and the growing acceptance of stenting solutions in outpatient settings are expected to drive the growth of specialty clinics in this market. Moreover, collaborations between specialty clinics and hospitals may further enhance the availability and effectiveness of duodenal stenting solutions.

Others:

The "Others" category encompasses various healthcare facilities and settings that may utilize duodenal stents for specific patient needs. This can include nursing homes, rehabilitation facilities, or even home healthcare services where temporary or palliative care is provided. The increasing focus on patient-centered care and the need for effective management of gastrointestinal issues in diverse settings highlight the importance of expanding the use of duodenal stents beyond traditional healthcare facilities. As awareness of alternative treatment options grows, this segment is likely to see an upsurge in the adoption of duodenal stenting solutions in non-hospital settings, contributing to overall market growth.

By Material Type

Nitinol:

Nitinol, a nickel-titanium alloy, is becoming increasingly popular in the manufacture of duodenal stents due to its unique properties, including superelasticity and shape memory. These attributes allow nitinol stents to return to their original shape after deployment, ensuring optimal support and reduced risk of migration post-placement. The biocompatibility of nitinol also minimizes the risk of adverse reactions and enhances patient comfort. As healthcare providers seek materials that improve the performance and longevity of stents, the preference for nitinol is expected to surge. Additionally, ongoing research into the advantages of nitinol stents over traditional materials will likely sustain their growing presence in the market.

Stainless Steel:

Stainless steel has long been a standard material for duodenal stents due to its strength and durability. Stainless steel stents provide reliable support for gastrointestinal structures, making them suitable for various applications. While they may not have the same flexibility as nitinol stents, their proven track record in clinical settings has established their reputation among surgeons. The cost-effectiveness of stainless steel stents also makes them an attractive option for healthcare facilities looking to manage expenses. As the market for duodenal stents evolves, stainless steel is expected to maintain a significant share, particularly in cost-sensitive environments.

Silicone:

Silicone stents are primarily used in situations requiring temporary support for the duodenum, particularly in cases involving benign obstructions. Their flexibility and biocompatibility make them well-suited for short-term applications, allowing for a less invasive approach to gastrointestinal management. The ease of placement and removal of silicone stents is an attractive feature for healthcare providers who may need to frequently adjust treatment plans. While they may not be suitable for long-term use, the effectiveness of silicone stents in providing immediate relief is ensuring their continued relevance in the duodenal stent market.

Polymer:

Polymer-based stents are emerging as an innovative solution in the duodenal stent market, featuring materials that can be tailored for specific patient needs. These stents can offer distinct advantages, such as controlled drug delivery for added therapeutic effects and customizable designs to fit unique anatomical conditions. The versatility of polymer materials allows for innovations that enhance stent performance while minimizing complications. With ongoing research into the use of biodegradable materials and drug-eluting technologies, the polymer segment is expected to grow significantly as healthcare providers recognize the potential benefits of incorporating these advanced stent solutions into their treatment protocols.

Others:

The "Others" category in material type consists of various alternative materials utilized in specialized duodenal stent applications. These may include bioabsorbable stents that dissolve over time, eliminating the need for surgical removal and reducing long-term risks associated with permanent implants. Innovations in materials science are continuously leading to the development of new stenting options that enhance patient safety and treatment effectiveness. As research progresses and clinicians seek tailored solutions for complex cases, this segment is anticipated to expand, contributing to the overall growth of the duodenal stent market.

By Region

The duodenal stent market exhibits significant regional variations, with North America commanding the largest market share. In 2025, North America is projected to account for approximately 40% of the global market, driven by advanced healthcare infrastructure, high demand for innovative medical devices, and a substantial patient population suffering from gastrointestinal disorders. The increasing prevalence of conditions requiring stenting, such as cancers and strictures, further supports the robust market presence in this region. Additionally, the presence of key market players and ongoing advancements in medical technology will enhance the North American market's growth, with an expected CAGR of 7.5% through 2035.

In Europe, the duodenal stent market is expected to witness steady growth, holding around 30% of the global market share in the coming years. Factors such as an aging population, rising healthcare expenditures, and a growing emphasis on minimally invasive procedures are driving this growth. The European market is characterized by high levels of innovation and product development, as well as a strong regulatory framework ensuring the safety and efficacy of stenting devices. The Asia Pacific region, while currently smaller in market share, is anticipated to exhibit the highest growth rate, fueled by increasing healthcare access, a growing patient population, and rising awareness of advanced treatment options. As healthcare systems in countries like China and India continue to evolve, the demand for duodenal stents will expand, contributing to the global market landscape.

Opportunities

As the duodenal stent market continues to expand, a myriad of opportunities exists for stakeholders looking to capitalize on this growth. One of the most notable opportunities is the rising demand for minimally invasive procedures, which aligns with the trend of outpatient care. Patients are increasingly favoring less invasive options that require shorter recovery times and lower risks of complications. This shift in patient preferences presents a significant opportunity for manufacturers of duodenal stents, as healthcare providers seek effective solutions that align with these needs. Additionally, the development of advanced materials and technologies, such as drug-eluting stents and bioabsorbable options, paves the way for innovative products that can address previously unmet medical needs. Companies investing in research and development to create these novel solutions will likely gain a competitive edge in the market.

Furthermore, the growing awareness of gastrointestinal health and the increasing prevalence of related disorders present additional opportunities for market expansion. Healthcare providers are prioritizing early detection and effective management of gastrointestinal diseases, driving the need for innovative treatment options such as duodenal stents. Emerging markets, particularly in Asia and Latin America, offer untapped potential for growth, as healthcare infrastructure improves and access to advanced treatment options increases. Collaborations between healthcare providers and medical device manufacturers can further enhance the distribution and accessibility of duodenal stents in these regions, ensuring that patients benefit from the latest advancements in gastrointestinal management.

Threats

The duodenal stent market faces several threats that could impact its growth trajectory. One of the primary concerns is the potential for complications associated with stent placement, such as migration, obstruction, or infection, which can deter healthcare providers from recommending stenting as a treatment option. Additionally, the emergence of alternative treatment modalities, such as surgical interventions and advanced endoscopy techniques, could pose a challenge to the market as healthcare providers explore various options to manage gastrointestinal disorders. The increasing scrutiny from regulatory bodies regarding the safety and efficacy of medical devices may also result in stricter regulations that could impede the introduction of new products into the market.

Moreover, pricing pressures from healthcare systems and payers are a constant challenge for manufacturers of duodenal stents. As the market becomes increasingly competitive, companies may be compelled to reduce prices to maintain their market share, thereby impacting profit margins and overall revenue. Additionally, the ongoing COVID-19 pandemic has introduced uncertainties in the healthcare sector, leading to delayed procedures and reduced patient visits, which could affect the demand for duodenal stents. Addressing these threats will require strategic planning and innovation from key market players to ensure sustainable growth in the face of potential challenges.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• Terumo Corporation
• B. Braun Melsungen AG
• Abbott Laboratories
• Conmed Corporation
• C. R. Bard, Inc. (BD)
• Ethicon, Inc. (Johnson & Johnson)
• EndoChoice, Inc.
• Olympus Corporation
• INNOVATIVE Health, Inc.
• Medtronic Intuitive Surgical
• Hologic, Inc.
• Silverleaf Medical, Inc.

The duodenal stent market is characterized by a competitive landscape with several key players vying for market share. Companies like Boston Scientific Corporation and Medtronic PLC are at the forefront of innovation, continually investing in research and development to enhance their product offerings. Boston Scientific, for instance, is recognized for its advanced stenting technologies, which are designed to improve patient outcomes and reduce complications. Medtronic, on the other hand, has a diverse portfolio of gastrointestinal devices, including stents, which allows it to cater to various patient needs. The competitive strategies of these companies often focus on product differentiation and technological advancements, ensuring they remain relevant in a rapidly evolving market.

Moreover, Cook Medical and Terumo Corporation are notable players in the duodenal stent market, known for their commitment to quality and innovation. Cook Medical's extensive range of stenting solutions addresses numerous gastrointestinal challenges, making it a preferred choice among healthcare providers. In contrast, Terumo Corporation is well-regarded for its advanced catheter-based delivery systems, which facilitate the effective placement of stents. As these companies continue to innovate and introduce new products, they play a crucial role in shaping the competitive landscape of the duodenal stent market.

In addition to these major players, companies like B. Braun Melsungen AG and Abbott Laboratories are also making significant strides in the duodenal stent market. B. Braun is known for its high-quality medical devices, and its focus on patient safety and satisfaction aligns well with the increasing demand for effective gastrointestinal solutions. Similarly, Abbott Laboratories has a strong presence in the medical device sector, with a range of products aimed at improving patient care. As competition intensifies, these companies will need to strategically position themselves to capitalize on market opportunities and navigate potential challenges.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cook Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hologic, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Medtronic PLC
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 EndoChoice, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Conmed Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Olympus Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 B. Braun Melsungen AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 C. R. Bard, Inc. (BD)
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 INNOVATIVE Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Silverleaf Medical, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Medtronic Intuitive Surgical
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Ethicon, Inc. (Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Duodenal Stent Sales Market, By user
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Others
  • 6.2 Duodenal Stent Sales Market, By Application
    • 6.2.1 Malignant Obstruction
    • 6.2.2 Benign Obstruction
    • 6.2.3 Fistula
    • 6.2.4 Pyloric Obstruction
    • 6.2.5 Others
  • 6.3 Duodenal Stent Sales Market, By Product Type
    • 6.3.1 Self-Expandable Metal Stents
    • 6.3.2 Plastic Stents
    • 6.3.3 Covered Stents
    • 6.3.4 Drug-Eluting Stents
    • 6.3.5 Others
  • 6.4 Duodenal Stent Sales Market, By Material Type
    • 6.4.1 Nitinol
    • 6.4.2 Stainless Steel
    • 6.4.3 Silicone
    • 6.4.4 Polymer
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Duodenal Stent Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Duodenal Stent Sales market is categorized based on

By Product Type

• Self-Expandable Metal Stents
• Plastic Stents
• Covered Stents
• Drug-Eluting Stents
• Others

By Application

• Malignant Obstruction
• Benign Obstruction
• Fistula
• Pyloric Obstruction
• Others

By user

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Material Type

• Nitinol
• Stainless Steel
• Silicone
• Polymer
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• Terumo Corporation
• B. Braun Melsungen AG
• Abbott Laboratories
• Conmed Corporation
• C. R. Bard, Inc. (BD)
• Ethicon, Inc. (Johnson & Johnson)
• EndoChoice, Inc.
• Olympus Corporation
• INNOVATIVE Health, Inc.
• Medtronic Intuitive Surgical
• Hologic, Inc.
• Silverleaf Medical, Inc.